Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bio-Rad Laboratories Sees FY24 Non-GAAP Currency-Neutral Revenue Growth ~1.0%-2.5%; Non-GAAP Operating Margin ~13.5%-14.0%

Author: Benzinga Newsdesk | February 15, 2024 05:18pm

Posted In: BIO